×


 x 

Shopping cart
. Ed(S): Timmins, Peter; Pygall, Samuel R.; Melia, Colin D. - Hydrophilic Matrix Tablets for Oral Controlled Release - 9781493915187 - V9781493915187
Stock image for illustration purposes only - book cover, edition or condition may vary.

Hydrophilic Matrix Tablets for Oral Controlled Release

€ 195.37
FREE Delivery in Ireland
Description for Hydrophilic Matrix Tablets for Oral Controlled Release hardcover. Hydrophilic Matrix Tablets for Oral Controlled Release Editor(s): Timmins, Peter; Pygall, Samuel R.; Melia, Colin D. Series: AAPS Advances in the Pharmaceutical Sciences Series. Num Pages: 335 pages, 65 black & white illustrations, 37 colour illustrations, 30 black & white tables, biograp. BIC Classification: TDCW. Category: (P) Professional & Vocational. Dimension: 242 x 164 x 17. Weight in Grams: 616.

This detailed volume addresses key issues and subtle nuances involved in developing hydrophilic matrix tablets as an approach to oral controlled release. It brings together information from more than five decades of research and development on hydrophilic matrix tablets and provides perspective on contemporary issues. Twelve comprehensive chapters explore a variety of topics including polymers (hypromellose, natural polysaccharides and polyethylene oxide) and their utilization in hydrophilic matrices, critical interactions impacting tablet performance, in vitro physical and imaging techniques, and microenvironmental pH control and mixed polymer approaches, among others. In one collective volume, Hydrophilic Matrix Tablets for Oral Controlled Release provides ... Read more

Show Less

Product Details

Format
Hardback
Publication date
2014
Publisher
Springer-Verlag New York Inc. United States
Number of pages
335
Condition
New
Series
AAPS Advances in the Pharmaceutical Sciences Series
Number of Pages
326
Place of Publication
New York, United States
ISBN
9781493915187
SKU
V9781493915187
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15

About . Ed(S): Timmins, Peter; Pygall, Samuel R.; Melia, Colin D.
Peter Timmins is Executive Director in Drug Product Science and Technology at Bristol-Myers Squibb Research and Development. His group, based in Moreton, U.K. and New Brunswick, USA, is responsible for creating, adapting, and applying drug delivery technology for oral drug candidates, including those requiring modified release technology. He has a degree in pharmacy and a PhD in pharmaceutical chemistry, both ... Read more

Reviews for Hydrophilic Matrix Tablets for Oral Controlled Release

Goodreads reviews for Hydrophilic Matrix Tablets for Oral Controlled Release


Subscribe to our newsletter

News on special offers, signed editions & more!